000			01841 a2200517 4500
005			20250516205847.0
264		0	_c20160115
008			201601s 0 0 eng d
022			_a1434-9949
024	7		_a10.1007/s10067-014-2601-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aVitale, Antonio
245	0	0	_aAnakinra treatment in patients with gout and type 2 diabetes. _h[electronic resource]
260			_bClinical rheumatology _cMay 2015
300			_a981-4 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAllopurinol _xtherapeutic use
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aColchicine _xtherapeutic use
650	0	4	_aDiabetes Mellitus, Type 2 _xcomplications
650	0	4	_aFebuxostat _xtherapeutic use
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aGout _xcomplications
650	0	4	_aGout Suppressants _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHyperuricemia _xblood
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aInterleukin 1 Receptor Antagonist Protein _xtherapeutic use
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPiperidines _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aUric Acid _xblood
700	1		_aCantarini, Luca
700	1		_aRigante, Donato
700	1		_aBardelli, Marco
700	1		_aGaleazzi, Mauro
773	0		_tClinical rheumatology _gvol. 34 _gno. 5 _gp. 981-4
856	4	0	_uhttps://doi.org/10.1007/s10067-014-2601-7 _zAvailable from publisher's website
999			_c23737896 _d23737896